WallStreetZenWallStreetZen

NYSE: RDY
Dr Reddys Laboratories Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Be the first to know when Wall Street analysts revise their RDY stock forecasts and price targets.

Forecast return on equity

Is RDY forecast to generate an efficient return?
Company
N/A
Industry
0.06%
Market
30.36%

Forecast return on assets

Is RDY forecast to generate an efficient return on assets?
Company
N/A
Industry
0.04%

RDY revenue forecast

What is RDY's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$3.3B+9.71%
Avg 2 year Forecast
$3.5B+17.52%
Avg 3 year Forecast
$3.7B+24.68%
RDY's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

RDY revenue growth forecast

How is RDY forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
7.7%
Industry
6.44%
Market
7.66%
RDY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
RDY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

RDY vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
RDY$68.86N/AN/A
NBIX$117.28$131.79+12.37%Buy
VTRS$9.83$10.33+5.12%Sell
TEVA$9.82$13.00+32.38%Strong Buy
CTLT$37.18$50.58+36.05%Buy
View Top Pharmaceutical Stocks

Dr Reddys Laboratories Stock Forecast FAQ

What is RDY's revenue growth forecast for 2024-2026?

(NYSE: RDY) Dr Reddys Laboratories's forecast annual revenue growth rate of 7.7% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 6.44%, and it is also forecast to beat the US market's average forecast revenue growth rate of 7.66%.

Dr Reddys Laboratories's revenue in 2023 is $2,988,320,369.On average, 2 Wall Street analysts forecast RDY's revenue for 2024 to be $546,477,045,242, with the lowest RDY revenue forecast at $543,067,386,981, and the highest RDY revenue forecast at $549,886,703,503. On average, 2 Wall Street analysts forecast RDY's revenue for 2025 to be $585,415,425,848, with the lowest RDY revenue forecast at $583,681,870,659, and the highest RDY revenue forecast at $587,148,981,037.

In 2026, RDY is forecast to generate $621,069,044,100 in revenue, with the lowest revenue forecast at $621,050,726,033 and the highest revenue forecast at $621,087,362,166.

If you're new to stock investing, here's how to buy Dr Reddys Laboratories stock.

What is RDY's forecast return on assets (ROA) for 2024-2026?

(NYSE: RDY) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 0.04%.

What is RDY's forecast return on equity (ROE) for 2024-2026?

(NYSE: RDY) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.